Dystonia in Huntington's disease: prevalence and clinical characteristics

Mov Disord. 1999 Jan;14(1):95-101. doi: 10.1002/1531-8257(199901)14:1<95::aid-mds1016>3.0.co;2-8.

Abstract

Background: The prevalence and clinical characteristics of dystonia in Huntington's disease (HD) have not been formally assessed.

Objectives: To study (1) the prevalence of dystonia in HD in a clinic population, (2) the clinical features of dystonia, and (3) clinical correlates of dystonia (for example, age, disease duration).

Methods: Patients with HD attending the HD Center at the New York State Psychiatric Center were administered the Unified HD Rating Scale and underwent a standardized 5.5-minute videotaped examination. Two neurologists reviewed the videotaped examination and rated the severity and constancy of dystonia, calculating a total dystonia score for each patient.

Results: Prevalence of dystonia of any severity was 95.2%. Twenty-four of 42 (57.1%) had dystonia in at least one body region that was moderate and present more than half of the time, and seven of 42 (16.7%) had dystonia that was severe and constant. The most prevalent types of dystonia were internal shoulder rotation (64.3%), sustained fist clenching (47.1%), excessive knee flexion (42.9%), and foot inversion (42.9%). In 37 of 42 (88.1%) patients, there were more than two types of dystonia, and in the average patient, three to four types of dystonia. The mean severity was between 1 (mild) and 2 (moderate), and the mean constancy was between 2 (present less than half of the time) and 3 (present more than half of the time). Multivariate linear regression revealed that disease duration (p = 0.0005) and taking an antidopaminergic agent (p = 0.03) were positively associated with the total dystonia score.

Conclusions: The majority of patients in this HD clinic exhibited some dystonia. The dystonia was present in several body regions and manifested by a variety of movements and postures not typical of idiopathic torsion dystonia. The dystonia was not bothersome to most patients, and its severity was a function of disease duration and use of an antidopaminergic agent.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Cross-Sectional Studies
  • Dopamine Antagonists / administration & dosage
  • Dopamine Antagonists / adverse effects
  • Dystonia / chemically induced
  • Dystonia / diagnosis*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination / drug effects
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / drug therapy
  • Risk Factors
  • Videotape Recording

Substances

  • Dopamine Antagonists